CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Profit & Loss Account Balance History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit & Loss Account Balance | ₹28,216 Cr | ₹25,644 Cr | ₹21,439 Cr | ₹18,057 Cr | ₹15,669 Cr |
What is the latest Profit & Loss Account Balance ratio of CIPLA ?
| Year | Profit & Loss Account Balance |
|---|---|
| Mar2026 | ₹28,216 Cr |
| Mar2025 | ₹25,644 Cr |
| Mar2024 | ₹21,439 Cr |
| Mar2023 | ₹18,057 Cr |
| Mar2022 | ₹15,669 Cr |
How is Profit & Loss Account Balance of CIPLA Trending?
| Years | Profit & Loss Account Balance | % Change | |
|---|---|---|---|
| Mar2026 | ₹28,216 Cr | 10.03 | |
| Mar2025 | ₹25,644 Cr | 19.62 | |
| Mar2024 | ₹21,439 Cr | 18.73 | |
| Mar2023 | ₹18,057 Cr | 15.24 | |
| Mar2022 | ₹15,669 Cr | - | |
Compare Profit & Loss Account Balance of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹111,490.2 Cr | -0.4% | -5.6% | -11.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,236.0 Cr | -1.8% | -3.7% | 17.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹249,673.0 Cr | 3.4% | 10.1% | 57.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹187,460.0 Cr | 1.6% | 0.8% | 37.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,220.3 Cr | -1.1% | -4.9% | -9.9% | Stock Analytics | |
| MANKIND PHARMA | ₹92,769.9 Cr | -3.6% | -7.4% | -11.2% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | -0.4% |
-5.6% |
-11.9% |
| SENSEX | -1.6% |
-4.2% |
-7.2% |
You may also like the below Video Courses